Cat. No.: HY-L022M

FDA-Approved Drug Library Mini

100 Cited Publications

Customer Review

Based on 100 publication(s) in Google Scholar

New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication. First, the risk of failure is lower. Second, the time frame for drug development can be reduced. Third, less investment is needed. Approved drugs have identified bioactivities, good pharmacokinetic characteristics and safety which are suitable for drug repurposing.

MCE owns a unique collection of 3,236 approved compounds which have been completed extensive preclinical and clinical studies and have well-characterized bioactivities, safety and bioavailability properties. The package of this library is 96-well microplate with peelable foil seal, which makes the screening process easier and faster.

PDF
Excel
SDF
Manual

Size

Price

Stock

Quantity

In-stock

(2-3 weeks)

Get a Quotation Now

In-stock

(2-3 weeks)

Get a Quotation Now

(2-3 weeks)

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Description & Advantages
Product Details
- Formulation
- Layout
- Container
- Storage
- Shipping
Publications (100)
Documentation
Composition

Description & Advantages

• A unique collection of 3,236 approved drugs for high throughput screening (HTS) and high content screening (HCS).

• Used in the research of oncology, cardiology, anti-inflammatory, immunology, dermatology, endocrinology, neurology, and more.

• A useful tool for researching new targets of marketed old drugs.

• All compounds have been approved by the FDA, EMA and other countries.

• Structurally diverse, bioactive, and cell permeable.

• More detailed compound information with structure, IC₅₀, and brief introduction.

• NMR and HPLC validated ensure high purity.

• All compounds are in stock and continuously updated.

	FDA-Approved Drug Library Mini	FDA-Approved Drug Library (Cat. No.: HY-L022)
Size	10 μL in DMSO	30, 50, 100, and 200 μL in DMSO
Package	96-well microplate with peelable foil seal	96-Well Format Sample Storage Tube With Screw Cap
Delivery Date	Within three days	About one month
Price Per Set	Low	High
Preparation For Use	Tear off the seal film on the microplate	If there is no robot, each tube needs to be manually opened

• Easily peelable foil seal makes the screening process easier and faster.

• Lower price, more compounds.

• Avoid multiple and uneven dispensing.

• Reduce risks of product cross-contamination.

• Avoid reduced activity due to long-term storage.

Product Details

Formulation

A collection of 3,236 marketed drugs supplied as pre-dissolved Solutions

Solution: 3,142 compounds supplied in 10 mM solution, 65 compounds supplied in 2 mM solution, 29 compounds supplied in 3 mg/mL solution.

Layout

96-well storage tube or 96-well plate: 1st and 12th column are left empty.
384-well plate: the first two columns and the last two columns are left empty.
Compounds with different concentrations or dissolved in different solvents will be put on separate plates.
This way of layout may increase the number of plates because there could be three solvents and three concentrations.
If you have other requirements, please let us know.

Container

96-well Plate With Peelable Foil Seal

Storage

-80°C

Shipping

Blue ice or dry ice